Latest news for  (OTC:KGCRF) Stock

B of A Securities analyst Andrew Obin maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Buy and raises the price target from $120 to $143.

News

Price Target

Analyst Ratings

B of A Securities Maintains Buy on 3M, Raises Price Target to $143

Trading Ideas

AAPL

Live On CNBC, Stephanie Link Announces Trimmed Apple

Barclays analyst Matthew Bouley maintains Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) with a Equal-Weight and raises the price target from $118 to $161.

Barclays Maintains Equal-Weight on Mohawk Industries, Raises Price Target to $161

Goldman Sachs analyst Brian Lee maintains Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) with a Buy and raises the price target from $104 to $116.

VLTO

Goldman Sachs Maintains Buy on Veralto, Raises Price Target to $116

Goldman Sachs analyst Noah Poponak maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Neutral and raises the price target from $94 to $104.

Goldman Sachs Maintains Neutral on RTX, Raises Price Target to $104

Barclays analyst Dan Levy maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Overweight and lowers the price target from $155 to $150.

Barclays Maintains Overweight on Lear, Lowers Price Target to $150

Goldman Sachs analyst Duffy Fischer maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Neutral and lowers the price target from $55 to $49.

Goldman Sachs Maintains Neutral on Olin, Lowers Price Target to $49

Macro Economic Events

Econ #s

Economics

U.S. DOE Finalizes Purchase Of 4.65M Barrels Of Crude For SPR; Crude To Be Delivered To Bayou Choctaw SPR Site In Louisiana From Oct-Dec; Exxon Mobil To Supply 3.9M Barrels, Macquarie Commodities Trading To Supply The Rest; Average Purchase Price For The Oil Was About $76.92 Per Barrel

Benchmark analyst Kurt Hallead maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Buy and raises the price target from $40 to $42.

Benchmark Maintains Buy on Baker Hughes, Raises Price Target to $42

Goldman Sachs analyst Susan Maklari maintains Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) with a Buy and raises the price target from $141 to $185.

Goldman Sachs Maintains Buy on Mohawk Industries, Raises Price Target to $185

Three of the world&#8217;s leading central banks are set to meet this week, posing one of the most crucial tests for markets as traders brace <a href="https://www.benzinga.com/topic/interest-rates">for interest rate shifts.</a>
The Federal Reserve will commence its two-day Federal Open Market Committee meeting Tuesday. The policy statement and Fed Chair Jerome Powell&#8216;s press conference are scheduled for 2 p.m. and 2:30 p.m. ET Wednesday, respectively.
Early on Wednesday morning, the Bank of Japan will hold a high-stakes meeting in Tokyo that could result in an interest rate move.
At 1 p.m. ET Thursday, the Bank of England will meet. Analysts perceive this as a tight decision between holding rates steady or enacting rate cut, which would be the first in over four years.
<h3 class="wp-block-heading">What to Expect From The Federal Reserve </h3>
The Fed is expected to keep interest rates unchanged at the upcoming FOMC meeting. Market-implied odds indicate a 95.6% chance that rates will remain on hold at 5.25-5.5%, with a rate cut fully priced in at the next meeting in September.
Traders will closely watch the Fed&#8217;s assessment of recent economic data, progress on inflation and whether Powell signals that a September rate cut is forthcoming.
&#8220;The Fed is optimistic that cuts are likely in the near term, but we do not think it is willing to signal September is a done deal,&#8221; wrote Bank of America this week.
Since the FOMC's June meeting, participants have noted better inflation readings in recent months following firmer prints in the first quarter.
&#8220;We've been very clear that you wouldn't wait for inflation to get all the way down to 2%&#8221; [before cutting interest rates,] Powell said in his latest public appearance this month.
He might also reiterate that an unexpected weakening in the labor market could prompt rate cuts.
&#8220;The main reason that the FOMC is closer to cutting is the favorable inflation news from May and June,&#8221; wrote Goldman Sachs economist David Mericle.
Goldman Sachs expects the FOMC to revise its statement to acknowledge &#8220;further progress&#8221; toward the 2% inflation goal, balancing the risks to the dual mandate more evenly and indicating that it now requires only &#8220;somewhat&#8221; greater confidence in the inflation outlook to start lowering interest rates.
<h3 class="wp-block-heading">What To Expect From The Bank of Japan</h3>
Considerable anxiety surrounds the Bank of Japan&#8217;s meeting, as the decision on a rate hike or hold remains uncertain.
Despite recent market volatility, Bank of America&#8217;s Japan and Asia economist Takayasu Kudo expects the BoJ to proceed with a small hike, raising the policy rate from the current zero to 0.1% to 0.25%. 
&#8220;The BoJ has indicated that it would adjust the degree of monetary easing further should the economy and prices move in line with its baseline scenario. Recent wage and price data, as well as the June BoJ Tankan, point to further progress in underlying inflation,&#8221; Kudo wrote.
The consensus view of economists tracked by TradingEconomics is for the BoJ to remain on hold.
In addition to a potential rate hike, the BoJ will announce details of its planned reduction in Japanese government bond purchases over the next one to two years, though uncertainties remain regarding the exact size and pace of these cuts.
The Japanese yen, tracked by the Invesco CurrencyShares Japanese Yen Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXY#NYSE">FXY</a>), has rallied over 4% in July against the dollar, marking its strongest month year-to-date, suggesting traders may be anticipating a rate hike.
<h3 class="wp-block-heading">Chart: Yen Rallies In July, Eyes Strongest-Performing Month Since December 2023 </h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="376" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56-1024x376.png" alt="" class="wp-image-462852" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56-1024x376.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56-300x110.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56-768x282.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56-1536x564.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29113502/image-56.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Image: <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro</a>
<h3 class="wp-block-heading">What To Expect From The Bank Of England</h3>
Bank of America&#8217;s U.K. economist Sonali Punhani expects the BoE to cut the Bank Rate by 25bps to 5% in August with a 5-4 vote, citing mixed data and a dovish stance, but emphasizes that this is a close call.
Punhani advises investors not to expect clear guidance on future rate paths, as the BoE is likely to focus on data and proceed cautiously with any future cuts, avoiding signaling the start of a sustained cutting cycle.
Goldman Sachs economist Sven Jari Stehn expects a similar outcome, also noting the decision to lower the Bank Rate is a close call and suggesting a low bar for the Monetary Policy Committee to delay the first cut until September.
&#8220;If the MPC does indeed lower the policy rate, then we would expect the updated guidance to be non-committal on the timing of further cuts,&#8221; Stehn said.
Earlier this month, the British pound reached 1.3045 against the U.S. dollar, its highest level in nearly a year. The Invesco CurrencyShares British Pound Sterling Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXB#NYSE">FXB</a>) is up 1.6% this month.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40013144/if-economic-performance-were-an-olympic-sport-us-economy-would-win-gold-says-market">If Economic Performance Were An Olympic Sport, &#8216;US Economy Would Win Gold,&#8217; Says Market Veteran</a></li>
</ul>
Illustration of Federal Reserve Chair Jerome Powell created using artificial intelligence via MidJourney.

Analyst Color

Asia

Specialty ETFs

Eurozone

Previews

Federal Reserve

Markets

ETFs

CurrencyShares British Pound Sterling Trust

Markets Brace For Crucial Interest Rate Shake-Up: What To Expect From Federal Reserve, Bank of Japan, Bank Of England This Week

Barclays analyst Theresa Chen maintains Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) with a Equal-Weight and raises the price target from $20 to $21.

Barclays Maintains Equal-Weight on Kinder Morgan, Raises Price Target to $21

As a leading voice in the plant medicine and psychedelic medicine space and the founder of the Mind Army, an organization &ldquo;Fighting For The Right to Pursue Happiness&rdquo; I&rsquo;ve witnessed firsthand the transformative power these substances have on individuals struggling with mental health and addiction. Now, more than ever, our nation is in dire need of innovative solutions to these crises. With the next election approaching, it&rsquo;s crucial that we ask the presidential candidates about their stance on legalizing and making these healing medicines accessible to all Americans.
The COVID-19 pandemic exacerbated many underlying issues, leading to a surge in mental health problems and addiction rates. Both Presidents Biden and Trump navigated the country through these tumultuous times, but as we emerge from the pandemic, we face a new challenge: a population experiencing mass PTSD. The evidence supporting the safety and efficacy of plant medicines, such as psilocybin mushrooms, in treating these conditions is overwhelming. The question now is, which candidate will take the bold step to legalize and make these therapies accessible?
Historically, the Biden/Harris administration has shown a willingness to explore progressive healthcare solutions. Reports suggest that Hunter Biden had a positive experience using plant medicine to overcome his addiction, sparking hope that the administration might consider broader legalization. However, the political climate often polarizes such issues, making it challenging to enact change. Vice President Harris has the opportunity to champion this cause, potentially transforming American healthcare by making safer, plant-based treatments more accessible. These natural medicines could replace traditional anti-depressants and alcohol, which often come with severe side effects, offering a safer and more effective alternative.
On the other hand, Donald Trump has demonstrated a pragmatic approach to healthcare, particularly with his &lsquo;Right to Try&rsquo; initiative, which empowers individuals to use unapproved treatments in desperate circumstances. This initiative underscores a fundamental belief in personal sovereignty over one&rsquo;s body, a principle that aligns with the ethos of the psychedelic movement. The younger members of Trump&rsquo;s organization, understanding the economic benefits of a mentally healthy and productive workforce, might also advocate for these treatments. Legalizing psychedelics could potentially reduce addiction and suicide rates, issues that are currently crippling our society.
Both candidates have the chance to make a historic impact. By committing to the legalization and accessibility of psychedelics, they can address the suicide epidemic and the fentanyl addiction crisis that ravages our nation. This commitment could also resonate deeply with a wide voter base. In the Midwest, for example, &lsquo;Moms on Mushrooms&rsquo; are already experiencing the benefits of microdosing psilocybin and are sharing their positive outcomes with others. These mothers, who often make the health decisions for their families, are a powerful demographic that could sway the election.
Trump&rsquo;s stance on the &lsquo;Right to Try&rsquo; could be extended to include psychedelics, offering veterans and others suffering from PTSD and addiction a new hope. It&rsquo;s reported that 20 times as many soldiers who died in combat have subsequently died by suicide. Providing access to these medicines could be the most significant contribution any president has made to veterans&rsquo; health.
A candidate who commits to this cause with integrity could win the election by a landslide, attracting voters who have directly experienced the healing potential of psychedelics. This issue transcends typical political divisions, touching the lives of individuals across the spectrum. It&rsquo;s time for both Biden/Harris&nbsp;and Trump to let the American people know where they stand on this crucial issue.
<img alt="ajg_9185.jpeg" src="https://www.benzinga.com/files/u1593113/ajg_9185.jpeg" style="height:450px; width:300px" />
Let&rsquo;s have this important conversation on podcasts and media platforms, pushing candidates to make their plans for psychedelic medicine clear. The mental health and productivity of our population depend on it.
By engaging in this dialogue, we can ensure that the next president prioritizes the health and well-being of all Americans through access to these transformative treatments.

Cannabis

Psychedelics

Politics

Media

General

The Psychedelic Vote: Why Candidates Should Embrace Plant Medicine

Goldman Sachs analyst Ryan Nash maintains First Hawaiian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>) with a Sell and raises the price target from $21 to $24.

Goldman Sachs Maintains Sell on First Hawaiian, Raises Price Target to $24

Benchmark analyst David Williams maintains Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) with a Buy and raises the price target from $120 to $145.

PLXS

Benchmark Maintains Buy on Plexus, Raises Price Target to $145

CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares are bouncing back Monday after facing heavy selling in recent trading sessions on the heels of a&nbsp;<a href="https://www.benzinga.com/news/24/07/39870313/microsoft-crowdstrike-issue-caused-largest-it-outage-in-history-showing-how-much-we-depend-on-a-hand" target="_blank" rel="noreferrer noopener">global IT outage</a>. Jim Cramer believes the stock has found a bottom and is <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">headed higher from here</a>.
What To Know: CrowdStrike shares are down more than 32% over the past month after a failed CrowdStrike update led to a major outage that impacted businesses across the world.
Monday on CNBC&#8217;s &#8220;Squawk On The Street,&#8221; Cramer predicted that the selling has run its course. 
&#8220;Yeah, I think it&#8217;s the bottom,&#8221; Cramer said.
He noted that he expected a bigger rise in shares of SentinelOne Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) and Palo Alto Networks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) following the hiccup from CrowdStrike. The market is telling you that there is not going to be a big change in market share here, Cramer said. 
See Also: <a href="https://www.benzinga.com/markets/equities/24/07/39975949/crowdstrike-ceo-george-kurtz-announces-over-97-of-windows-sensors-back-online-after-global-outag">CrowdStrike CEO George Kurtz Announces Over 97% Of Windows Sensors Back Online After Global Outage</a>
Last week, Cramer<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39888488/jim-cramer-applauds-crowdstrikes-response-to-global-it-outage-sees-swift-recovery-ahead-"> applauded</a> CrowdStrike CEO George Kurtz&#8217;s response to the event and suggested that the selling in CrowdStrike shares would be short-lived. Kurtz immediately accepted blame for the outage last week, explaining that the issues were caused by &#8220;a defect found in a single content update.&#8221; 
Cramer said at the time that he expected people to forget about the security incident and return to CrowdStrike within three months because of the company&#8217;s &#8220;unbelievable technology.&#8221;
Cramer on Monday highlighted recent analyst commentary including high praise from JPMorgan calling the company a &#8220;masterclass on incident response,&#8221; a call for upside from current levels from UBS and a positive Morgan Stanley note, showing strong global reseller data.
&#8220;There are a lot of people calling the bottom,&#8221; Cramer said, adding that he is one of them. 
Although he acknowledged that the selloff was probably warranted given the magnitude of the IT outage, he believes Kurtz has done a good job showing people that CrowdStrike is a winner, not a loser, he said. 
CrowdStrike is due to report <a href="https://www.benzinga.com/calendars/earnings">earnings for the second quarter</a> sometime near the end of August. The cybersecurity company is expected to report earnings of 98 cents per share and revenue of $958.795 million, according to estimates from&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
CRWD Price Action: <a href="http://benzinga.com/quote/crwd" target="_blank" rel="noreferrer noopener">CrowdStrike shares</a> were up 3.02% at $263.62 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/startups/24/07/39963188/to-no-ones-surprise-jim-cramer-praised-crowdstrike-less-than-two-months-ago-i-dont-think-that-domino">To No One&#8217;s Surprise, Jim Cramer Praised CrowdStrike Less Than Two Months Ago &#8216;I Don&#8217;t Think That Domino Is Going To Fall&#8217;</a></li>
</ul>
Photo: Shutterstock.

Long Ideas

CRWD

PANW

Jim Cramer Joins Multiple Analysts Calling The Bottom In CrowdStrike Stock

Barclays analyst Jared Shaw maintains First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) with a Equal-Weight and raises the price target from $29 to $31.

FIBK

Barclays Maintains Equal-Weight on First Interstate BancSys, Raises Price Target to $31

Goldman Sachs analyst Ryan Nash maintains Bread Finl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>) with a Sell and raises the price target from $40 to $53.

Goldman Sachs Maintains Sell on Bread Finl Hldgs, Raises Price Target to $53

Goldman Sachs analyst Neil Mehta maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Buy and raises the price target from $39 to $43.

Goldman Sachs Maintains Buy on Baker Hughes, Raises Price Target to $43

<a href="https://cloud.google.com/blog/products/databases/announcing-iam-group-authentication-in-cloud-sql/">https://cloud.google.com/blog/products/databases/announcing-iam-group-authentication-in-cloud-sql/</a>
&nbsp;
Managing and auditing data access can be very complex at scale, in particular, for a fleet of databases with a myriad of users. Today, we're launching <a href="https://cloud.google.com/sql/docs/postgres/iam-authentication#iam-group-auth">Identity and Access Management (IAM) group authentication</a> in <a href="https://cloud.google.com/sql?hl=en">Cloud SQL for PostgreSQL and Cloud&nbsp; SQL for MySQL</a>, simplifying user management and database authentication. Now, developers, database administrators, and security admins can benefit from simplified database access, better security controls, and more efficient user management at scale.
Cloud SQL IAM group authentication allows customers to use <a href="https://cloud.google.com/identity/docs/overview">Google Cloud Identity</a> groups to manage access to Cloud SQL instances and databases. IAM group authentication extends existing IAM database authentication functionality by allowing database access to be managed at the group level instead of the individual user level.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

News

Latest news for (OTC:KGCRF) Stock